All In MedTech

FDA Clearance Tracker · P090022

LENSTEC SOFTEC HD POSTERIOR CHAMBER INTRAOCULAR LENS

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Apr 12, 2010 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Apr 12, 2010

Approved

Time to decision

223 days

Received Sep 1, 2009. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P090022
Device name
LENSTEC SOFTEC HD POSTERIOR CHAMBER INTRAOCULAR LENS
Applicant
Lenstec, Inc.
Applicant location
St. Petersburg, FL
Received
Sep 1, 2009
Decided
Apr 12, 2010
Decision
Approved
Supplements
42 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code HQL

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE SOFTEC HD POSTERIOR CHAMBER INTRAOCULAR LENS (PCIOL). THE DEVICE IS INDICATED FOR THE REPLACEMENT OF THE HUMAN CRYSTALLINE LENS FOLLOWING PHACOEMULSIFICATION CATARACT REMOVAL IN ADULTS OVER THE AGE OF 21. THE LENS IS INDICATED FOR CAPSULAR BAG PLACEMENT.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code HQL. The earliest in FDA's data is K771933, decided Jan 26, 1978.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Lenstec, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.